Tianjin North Network News: As one of the "Eight Projects" to support and lead the high-quality development of Binhai New Area, we are accelerating the construction of modern industrial clusters. Binhai New Area is leveraging the attractiveness of the Cell Ecology Haihe Laboratory for talent projects and related enterprises, and striving to build a biopharmaceutical industry cluster. The "Ten Actions" research tour, to see the…
2023-03-04
According to the Municipal Commission of Economy and Information Technology, on February 28th, the National Drug Administration (NMPA) issued a "Drug Registration Certificate" to Shanghai Shengdi Pharmaceutical Co., Ltd., which independently developed the PD-L1 inhibitor Adebelizumab (trade name: Arili). This drug is the first domestically developed PD-L1 inhibitor approved for small cell lung cancer indications in China, bringing patie…
2023-03-04
CopyRight 2023 Guangzhou Baoliangde Plastic Technology Co., Ltd
粤ICP备18143444号
